SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajooni Biotech develops lumpy skin disease medicine for cattle

07 Sep 2022 Evaluate

Ajooni Biotech has successfully done research and development of lumpy skin disease medicine for cattle.  Ajooni is fully committed to build and sustain itself as an organization where Innovation is a key driver. Company is constantly experimenting and working on research-based different health care solutions by a strong Research & Development team, working closely with leading research agencies, universities and independent scientists for product and process development. Its focus is to develop cost effective solutions to improve animal health, sustainable productivity of dairy and poultry farm, and thereby, the profitability of farmers.

The recent fast-spreading outbreak of lumpy skin disease (LSD) in cattle is estimated to have infected large number of animals particularly cows across India and over thousands of head of cattle have succumbed to the disease. Farmers and cattle-rearing communities in the affected areas are badly suffering with the fast spread of this disease.

Ajooni Biotech has been working for the last few months to develop new medicines to control Lumpy Skin disease as a part of its regular research work and has been successful to produce a most effective formula at very reasonable cost by its expert team of Doctors and Scientists.

Ajooni Biotech is a paramount manufacturer and supplier of superior quality of Patanjali Samvriddhi, Patanjali Garbhanjali, Patanjali Batisa-Pro etc.

Peers
Company Name CMP
Godrej Agrovet 610.05
Avanti Feeds 1474.15
KSE 202.95
Mukka Proteins 24.20
Prima Agro 15.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×